MX18106A - Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades. - Google Patents

Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades.

Info

Publication number
MX18106A
MX18106A MX1810689A MX1810689A MX18106A MX 18106 A MX18106 A MX 18106A MX 1810689 A MX1810689 A MX 1810689A MX 1810689 A MX1810689 A MX 1810689A MX 18106 A MX18106 A MX 18106A
Authority
MX
Mexico
Prior art keywords
amidinic
pneumonia
diseases
compounds
treatment
Prior art date
Application number
MX1810689A
Other languages
English (en)
Inventor
Richard R Tidwell
Original Assignee
Richard R Tidwell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard R Tidwell filed Critical Richard R Tidwell
Publication of MX18106A publication Critical patent/MX18106A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX1810689A 1988-10-25 1989-10-25 Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades. MX18106A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/262,535 US4933347A (en) 1988-10-25 1988-10-25 Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia

Publications (1)

Publication Number Publication Date
MX18106A true MX18106A (es) 1994-01-31

Family

ID=22997911

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1810689A MX18106A (es) 1988-10-25 1989-10-25 Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades.

Country Status (2)

Country Link
US (1) US4933347A (es)
MX (1) MX18106A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366726A (en) * 1987-12-23 1994-11-22 The Regents Of The University Of California Suppression of Pneumocystis carinii using aerosolized pentamidine treatment
US5364615A (en) * 1987-12-23 1994-11-15 Regents Of The University Of California Prophylaxis of pneumocystis carinii with aerosilized pentamidine
US5206236A (en) * 1989-04-06 1993-04-27 Tidwell Richard R Method for the treatment of malaria
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
US5488160A (en) * 1991-06-11 1996-01-30 Ciba-Geigy Corporation Amidino compounds, their manufacture and method of treatment
EP0574921B1 (en) * 1992-06-19 2002-01-16 Sony Corporation Laser beam generator
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
CA2147605A1 (en) * 1992-10-23 1994-05-11 Michael R. Green Small molecule inhibition of rna/ligand binding
US5455274A (en) * 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives
US6815461B1 (en) 1994-01-20 2004-11-09 The University Of North Carolina At Chapel Hill Method of inhibiting retroviral integrase
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
US5668165A (en) * 1995-06-07 1997-09-16 Scriptgen Pharmaceuticals, Inc. Small molecule inhibition of RNA/ligand binding
US5668167A (en) * 1995-06-07 1997-09-16 Duke University Methods of treating microbial infections
US5723495A (en) * 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
AU770656B2 (en) 1998-09-17 2004-02-26 Duke University Antifungal activity of dicationic molecules
US6677377B2 (en) * 2000-06-21 2004-01-13 Georgetown University School Of Medicine Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions
CN1658852A (zh) * 2001-08-31 2005-08-24 神经化学（国际）有限公司 用于治疗淀粉样变性的脒衍生物
JP3857916B2 (ja) * 2001-12-20 2006-12-13 日本電信電話株式会社 ２モジュラスプリスケーラ回路
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
WO2005089738A2 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections

Also Published As

Publication number Publication date
US4933347A (en) 1990-06-12

Similar Documents

Publication Publication Date Title
MX18106A (es) Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades.
MX9202436A (es) Composiciones para el cuidado del cabello y metodo para su preparacion.
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE3769458D1 (de) Physiologisch wirksame und naehrende zusammensetzung.
IT8920413A0 (it) Procedimento per la preparazione di l alfa glicerilfosforilcolina e l alfa glicerilfosforiletanolammina.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
ES2013727B3 (es) Procedimiento para la fabricacion de articulos de cerdas y articulos de cerdas fabricadas por dicho procedimiento.
ATE92542T1 (de) Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor|than.
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
MX9102792A (es) D-aminoacido-axidasa inmovilizada y su empleo para la preparacion de medicamentos.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .
ES549671A0 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
MX9200555A (es) Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.
FI941707A (fi) Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan
DE3854008D1 (de) Keramisches Substrat und Herstellung desselben.
MX9100540A (es) Procedimiento para el tratamiento de gases y la aplicacion de cuerpos de rellenos elipsoidales.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
ATE104850T1 (de) Naphtochinone zur behandlung und prophylaxe von pneumocystis carinii-infektionen.